Bogart Wealth LLC Grows Stake in Veeva Systems Inc. $VEEV

Key Points

• Bogart Wealth LLC increased its stake in Veeva by 33,268.7% in Q4, acquiring an additional 32,936 shares to hold 33,035 shares worth $7.374 million.
• Veeva beat Q3 expectations (EPS $2.06 vs. $1.94; revenue $835.95M, +16% YoY), has issued FY/Q1 2027 guidance, and its board authorized a $2.0 billion share buyback (up to 5.5% of shares).
• Analyst sentiment is mixed: the consensus is a "Moderate Buy" with an average target of $278.70, but several firms have cut targets or downgraded the stock recently.

Bogart Wealth LLC increased its stake in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 33,268.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,035 shares of the technology company's stock after acquiring an additional 32,936 shares during the period. Bogart Wealth LLC's holdings in Veeva Systems were worth $7,374,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Jensen Investment Management Inc. grew its holdings in Veeva Systems by 1,924.5% during the 3rd quarter. Jensen Investment Management Inc. now owns 413,213 shares of the technology company's stock valued at $123,100,000 after purchasing an additional 392,802 shares during the last quarter. Alphinity Investment Management Pty Ltd bought a new position in Veeva Systems during the 3rd quarter valued at about $422,241,000. Principal Financial Group Inc. grew its holdings in Veeva Systems by 11.2% during the 3rd quarter. Principal Financial Group Inc. now owns 3,846,877 shares of the technology company's stock valued at $1,146,040,000 after purchasing an additional 388,864 shares during the last quarter. Compass Wealth Management LLC bought a new position in Veeva Systems during the 3rd quarter valued at about $18,694,000. Finally, ABN AMRO Bank N.V. bought a new position in Veeva Systems during the 3rd quarter valued at about $246,625,000. Hedge funds and other institutional investors own 88.20% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on VEEV shares. Royal Bank Of Canada cut their price target on shares of Veeva Systems from $330.00 to $275.00 and set an "outperform" rating on the stock in a report on Thursday, March 5th. Wall Street Zen downgraded shares of Veeva Systems from a "buy" rating to a "hold" rating in a report on Sunday, March 22nd. UBS Group upped their price target on shares of Veeva Systems from $200.00 to $220.00 and gave the company a "neutral" rating in a report on Thursday, March 5th. Citigroup downgraded shares of Veeva Systems from a "buy" rating to a "neutral" rating and cut their price target for the company from $291.00 to $176.00 in a report on Friday, April 10th. Finally, Needham & Company LLC dropped their target price on shares of Veeva Systems from $355.00 to $270.00 and set a "buy" rating on the stock in a research note on Thursday, March 5th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Veeva Systems presently has an average rating of "Moderate Buy" and an average target price of $278.70.

Insider Buying and Selling

In related news, Director Priscilla Hung sold 750 shares of the stock in a transaction that occurred on Friday, April 10th. The shares were sold at an average price of $153.50, for a total transaction of $115,125.00. Following the completion of the sale, the director owned 4,003 shares of the company's stock, valued at $614,460.50. This represents a 15.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.30% of the stock is owned by insiders.

Veeva Systems Stock Down 1.1%

NYSE:VEEV opened at $158.61 on Wednesday. Veeva Systems Inc. has a 52 week low of $148.05 and a 52 week high of $310.50. The firm has a 50 day moving average of $175.69 and a 200 day moving average of $218.09. The stock has a market capitalization of $25.91 billion, a price-to-earnings ratio of 29.32, a PEG ratio of 0.72 and a beta of 1.10.

Veeva Systems (NYSE:VEEV - Get Free Report) last posted its earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, beating analysts' consensus estimates of $1.94 by $0.12. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. The company had revenue of $835.95 million during the quarter, compared to analysts' expectations of $810.95 million. During the same quarter in the prior year, the company posted $1.74 earnings per share. Veeva Systems's revenue for the quarter was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, analysts expect that Veeva Systems Inc. will post 6.41 EPS for the current year.

Veeva Systems declared that its board has initiated a share buyback program on Monday, January 5th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the technology company to buy up to 5.5% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its stock is undervalued.

About Veeva Systems

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.